PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 97 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $562,000 | +19.1% | 104,874 | +14.0% | 0.00% | 0.0% |
Q4 2018 | $472,000 | -68.4% | 91,994 | -40.3% | 0.00% | 0.0% |
Q3 2018 | $1,494,000 | +90.6% | 153,994 | +100.3% | 0.00% | 0.0% |
Q2 2018 | $784,000 | +36.6% | 76,897 | +74.2% | 0.00% | 0.0% |
Q1 2018 | $574,000 | -26.6% | 44,137 | +1.0% | 0.00% | 0.0% |
Q4 2017 | $782,000 | -27.9% | 43,686 | +1.1% | 0.00% | 0.0% |
Q3 2017 | $1,084,000 | +5.1% | 43,191 | +1.0% | 0.00% | 0.0% |
Q2 2017 | $1,031,000 | +58.4% | 42,773 | +26.5% | 0.00% | 0.0% |
Q1 2017 | $651,000 | +66.5% | 33,814 | +33.3% | 0.00% | 0.0% |
Q4 2016 | $391,000 | +19.9% | 25,363 | +1.1% | 0.00% | 0.0% |
Q3 2016 | $326,000 | +11.6% | 25,093 | +19.5% | 0.00% | 0.0% |
Q2 2016 | $292,000 | +9.4% | 21,001 | +19.3% | 0.00% | – |
Q1 2016 | $267,000 | -20.1% | 17,609 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $334,000 | -0.3% | 17,609 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $335,000 | -26.2% | 17,609 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $454,000 | – | 17,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |